Safety Challenges To Nanotech Commercialization Identified By Survey Of Northeast Firms

Main Category: Public Health
Article Date: 13 Dec 2007 - 5:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

The Project on Emerging Nanotechnologies have released the results of a new survey of New England-based nanotechnology companies aimed at discovering how firms in almost every sector of the economy address the possible environmental, health and safety (EHS) impacts of new nanoscale materials and products. The survey found that these firms lack a clear roadmap of government EHS expectations and regulations for successful commercialization, as well as the information needed to meet those expectations.

Last year, worldwide investment in nanotechnology topped $12 billion dollars and the value of nanotechnology goods manufactured globally reached $50 billion. But the survey indicates that as nanotech industrial and consumer applications enter the market, U.S. companies need more information and guidance from suppliers, trade associations, government regulatory bodies and others to manage risks effectively.

The report, authored by John Lindberg and Margaret Quinn of the University of Massachusetts Lowell, is drawn from an online survey distributed to 180 managers from nanotechnology firms in the Northeast. It included in-depth, follow-up interviews with 12 firms.

The region is home to one of the greatest concentrations of companies, universities, government laboratories and organizations working on nanotechnology in America. Some firms in the study are located in Cambridge, Mass., the nation's second locality to consider a nanotechnology reporting ordinance.

Lindberg and Quinn found that 80 percent of large firms were taking steps to manage nanotechnology EHS risks, compared to only 33 percent of small and micro companies and 12 percent of firms at start-up stage.

John Lindberg, the principal investigator on the study said, "Many smaller firms recognize the need to address risks proactively, but few have the resources to do so. At present, the majority of survey participants expect to rely on suppliers to provide nanomaterial risk management information in the form of Materials Safety Data Sheets (MSDS). But these do not always reflect the latest health and safety information, and regulatory or consensus guidance for these new materials is lacking."

David Rejeski, director of the Project on Emerging Nanotechnologies, noted, "The current MSDS for carbon nanotubes sold over the Internet treats them as graphite - the same material used in pencils - despite nanotubes bearing no more than a passing resemblance to this material. Clearly, companies are not being given the guidance they need. The findings from this study are consistent with other surveys of nanotech businesses in California, New York, and around the world. Firms are flying somewhat blind into the future and need a clear set of rules, a sense of the emerging regulatory landscape, and access to relevant research on risks in order to ensure both nanotechnology safety and profits."

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

About Nanotechnology

Nanotechnology is the ability to measure, see, manipulate and manufacture things usually between 1 and 100 nanometers. A nanometer is one billionth of a meter; a human hair is roughly 100,000 nanometers wide. By 2014, Lux Research projects that $2.6 trillion in global manufactured goods will incorporate nanotechnology, or about 15 percent of total global output.

The Project on Emerging Nanotechnologies is an initiative launched by the Woodrow Wilson International Center for Scholars and The Pew Charitable Trusts in 2005. It is dedicated to helping business, government and the public anticipate and manage possible health and environmental implications of nanotechnology.

Source: Colin Finan
Project on Emerging Nanotechnologies